Search research articles
Contact Us
Filters
Showing results (111-120 of 154) with videos related to
Page
of 16
Sort By:
The Journal of Urology
|
January 9, 2023
Reply by Authors
Michael T Schweizer, Lawrence True, Roman Gulati, et al.
Oncotarget
|
October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
Lisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.
Plos One
|
October 31, 2014
Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis
Elahe A Mostaghel, Andrew Morgan, Xiaotun Zhang, et al.
Cell Reports
|
May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
JCO Precision Oncology
|
January 9, 2023
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG-Avid Discordant Findings
Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, et al.
Journal of the National Cancer Institute
|
November 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
Yibai Zhao, Roman Gulati, Zhenwei Yang, et al.
European Urology
|
June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts
Hung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
Hung-Ming Lam, Ryan McMullin, Holly M Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot study
Elahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 154) with videos related to
Sort By:
Page
of 16
The Journal of Urology
|
January 9, 2023
Reply by Authors
Michael T Schweizer, Lawrence True, Roman Gulati, et al.
Oncotarget
|
October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways
Lisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.
Plos One
|
October 31, 2014
Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis
Elahe A Mostaghel, Andrew Morgan, Xiaotun Zhang, et al.
Cell Reports
|
May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
JCO Precision Oncology
|
January 9, 2023
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer
Heather H Cheng, Alexandra O Sokolova, Roman Gulati, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG-Avid Discordant Findings
Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, et al.
Journal of the National Cancer Institute
|
November 20, 2024
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling
Yibai Zhao, Roman Gulati, Zhenwei Yang, et al.
European Urology
|
June 23, 2019
Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived Xenografts
Hung-Ming Lam, Holly M Nguyen, Mark P Labrecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived Xenografts
Hung-Ming Lam, Ryan McMullin, Holly M Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2013
Targeted androgen pathway suppression in localized prostate cancer: a pilot study
Elahe A Mostaghel, Peter S Nelson, Paul Lange, et al.
Page
of 16